Banvit Bandirma Vitaminli Yem Sanayi AS
IST:BANVT.E
Banvit Bandirma Vitaminli Yem Sanayi AS
IST:BANVT.E
Price:
245
TRY
1.24%
Market Closed
Market Cap:
24.5B
TRY
Balance Sheet
Balance Sheet Decomposition
Banvit Bandirma Vitaminli Yem Sanayi AS
Banvit Bandirma Vitaminli Yem Sanayi AS
| Current Assets | 11.4B |
| Cash & Short-Term Investments | 3.5B |
| Receivables | 3.2B |
| Other Current Assets | 4.7B |
| Non-Current Assets | 5.9B |
| PP&E | 5.8B |
| Intangibles | 59.2m |
| Other Non-Current Assets | 415.9k |
Balance Sheet
Banvit Bandirma Vitaminli Yem Sanayi AS
Banvit Bandirma Vitaminli Yem Sanayi AS
Currency: TRY
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
17
|
8
|
16
|
171
|
295
|
530
|
769
|
608
|
1 296
|
|
| Cash |
12
|
8
|
11
|
64
|
104
|
126
|
339
|
427
|
637
|
|
| Cash Equivalents |
6
|
1
|
5
|
106
|
191
|
404
|
430
|
181
|
659
|
|
| Short-Term Investments |
0
|
23
|
40
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
187
|
164
|
265
|
303
|
304
|
360
|
570
|
1 448
|
2 045
|
|
| Accounts Receivables |
186
|
157
|
259
|
292
|
299
|
357
|
559
|
1 293
|
1 750
|
|
| Other Receivables |
1
|
7
|
7
|
11
|
5
|
2
|
11
|
155
|
294
|
|
| Inventory |
208
|
249
|
377
|
408
|
489
|
674
|
1 415
|
3 176
|
2 814
|
|
| Other Current Assets |
26
|
25
|
36
|
106
|
94
|
341
|
277
|
1 613
|
1 194
|
|
| Total Current Assets |
439
|
470
|
734
|
987
|
1 181
|
1 906
|
3 015
|
7 051
|
7 429
|
|
| PP&E Net |
529
|
551
|
575
|
514
|
814
|
666
|
755
|
4 625
|
5 035
|
|
| PP&E Gross |
529
|
551
|
575
|
514
|
814
|
666
|
755
|
4 625
|
5 035
|
|
| Accumulated Depreciation |
378
|
393
|
437
|
387
|
440
|
417
|
438
|
204
|
490
|
|
| Intangible Assets |
4
|
4
|
5
|
4
|
3
|
4
|
4
|
104
|
97
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
23
|
0
|
0
|
6
|
6
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
53
|
40
|
26
|
40
|
43
|
87
|
39
|
418
|
17
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1 051
N/A
|
1 088
+4%
|
1 340
+23%
|
1 545
+15%
|
2 048
+33%
|
2 669
+30%
|
3 812
+43%
|
12 200
+220%
|
12 578
+3%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
241
|
184
|
324
|
421
|
455
|
664
|
1 202
|
3 856
|
3 887
|
|
| Accrued Liabilities |
1
|
1
|
1
|
2
|
1
|
1
|
0
|
0
|
0
|
|
| Short-Term Debt |
352
|
164
|
283
|
215
|
61
|
179
|
336
|
2 271
|
1 410
|
|
| Current Portion of Long-Term Debt |
116
|
83
|
2
|
1
|
83
|
187
|
471
|
597
|
62
|
|
| Other Current Liabilities |
20
|
29
|
45
|
51
|
60
|
99
|
156
|
323
|
1 138
|
|
| Total Current Liabilities |
729
|
460
|
655
|
690
|
659
|
1 131
|
2 164
|
7 047
|
6 496
|
|
| Long-Term Debt |
18
|
214
|
0
|
49
|
158
|
382
|
318
|
232
|
93
|
|
| Deferred Income Tax |
37
|
41
|
41
|
43
|
92
|
92
|
0
|
452
|
70
|
|
| Other Liabilities |
47
|
49
|
30
|
32
|
45
|
60
|
86
|
467
|
854
|
|
| Total Liabilities |
832
N/A
|
764
-8%
|
726
-5%
|
814
+12%
|
954
+17%
|
1 665
+75%
|
2 568
+54%
|
8 198
+219%
|
7 513
-8%
|
|
| Equity | ||||||||||
| Common Stock |
100
|
100
|
100
|
100
|
100
|
100
|
100
|
100
|
100
|
|
| Retained Earnings |
134
|
71
|
183
|
263
|
374
|
196
|
311
|
3 084
|
4 671
|
|
| Unrealized Security Profit/Loss |
0
|
237
|
237
|
218
|
449
|
427
|
414
|
152
|
436
|
|
| Other Equity |
36
|
58
|
94
|
150
|
171
|
280
|
419
|
665
|
142
|
|
| Total Equity |
219
N/A
|
324
+48%
|
614
+89%
|
732
+19%
|
1 094
+50%
|
1 004
-8%
|
1 244
+24%
|
4 001
+222%
|
5 065
+27%
|
|
| Total Liabilities & Equity |
1 051
N/A
|
1 088
+4%
|
1 340
+23%
|
1 545
+15%
|
2 048
+33%
|
2 669
+30%
|
3 812
+43%
|
12 200
+220%
|
12 578
+3%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
100
|
100
|
100
|
100
|
100
|
100
|
100
|
100
|
100
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
